Institutional Ownership Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA). We have compiled data on the 290 institutions that hold shares in the stock, with a total of 233 Million shares, which have been reported (via 13F filing form) to have a value of $520 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Mhr Fund Management LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
28,967,103
shares
|
$64.6 Million
8.78% of portfolio
|
Q2 2025
Added 18.63%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
25,076,472
shares
|
$55.9 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.72%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
21,225,119
shares
|
$47.3 Million
0.0% of portfolio
|
Q2 2024
Added 6.5%
|
|
|
Long Focus Capital Management, LLC
San Juan, PR |
Aug 14, 2025 Q2 2025 |
11,820,000
shares
|
$26.4 Million
0.94% of portfolio
|
Q2 2025
Added 27.78%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
9,890,525
shares
|
$22.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 10.42%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
9,330,223
shares
|
$20.8 Million
0.01% of portfolio
|
Q2 2025
Added 5793.16%
|
|
|
Invenomic Capital Management LP
Boston, MA |
Aug 14, 2025 Q2 2025 |
8,294,663
shares
|
$18.5 Million
0.83% of portfolio
|
Q2 2025
Added 51.09%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
6,450,933
shares
|
$14.4 Million
0.0% of portfolio
|
Q2 2025
Added 60.54%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
6,189,058
shares
|
$13.8 Million
0.0% of portfolio
|
Q2 2025
Added 3.7%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
5,175,080
shares
|
$11.5 Million
0.04% of portfolio
|
Q2 2023
Added 436.67%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
4,887,200
shares
|
$10.9 Million
0.01% of portfolio
|
Q2 2025
Added 39.18%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
4,749,876
shares
|
$10.6 Million
0.0% of portfolio
|
Q2 2025
Reduced 14.75%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
4,633,451
shares
|
$10.3 Million
0.02% of portfolio
|
Q2 2025
Added 1067.13%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Aug 08, 2025 Q2 2025 |
4,601,441
shares
|
$10.3 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.97%
|
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
May 14, 2025 Q1 2025 |
4,407,713
shares
|
$9.83 Million
0.03% of portfolio
|
Q1 2025
Reduced 2.96%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
4,113,588
shares
|
$9.17 Million
0.0% of portfolio
|
Q2 2025
Added 137.4%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
4,029,568
shares
|
$8.99 Million
0.0% of portfolio
|
Q2 2025
Added 33.55%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
Aug 14, 2025 Q2 2025 |
3,429,329
shares
|
$7.65 Million
1.33% of portfolio
|
Q2 2025
Added 6.79%
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
3,261,707
shares
|
$7.27 Million
0.43% of portfolio
|
Q2 2025
Reduced 58.1%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
2,928,736
shares
|
$6.53 Million
0.0% of portfolio
|
Q2 2025
Reduced 16.47%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
2,379,088
shares
|
$5.31 Million
0.0% of portfolio
|
Q2 2025
Added 354.99%
|
|
|
Orion Investment CO
St. Louis, MO |
Aug 14, 2025 Q2 2025 |
2,338,563
shares
|
$5.21 Million
1.42% of portfolio
|
Q2 2025
Added 98.71%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
2,334,900
shares
|
$5.21 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
2,119,787
shares
|
$4.73 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.55%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
2,114,190
shares
|
$4.71 Million
0.0% of portfolio
|
Q2 2025
Reduced 12.06%
|